E-LIB Suche - Ergebnisse für: Barthelemy, P.

1

Nivolumab plus ipilimumab versus sunitinib for first-line t..:

Tannir, N.M. ; Albigès, L. ; McDermott, D.F....
Annals of Oncology. , 2024

Link: https://doi.org/10.1016/..

2

Nivolumab in patients with advanced renal cell carcinoma in..:

Barthélémy, P. ; Albigès, L. ; Escudier, B....
ESMO Open. 9 (2024) 7 - p. 103602 , 2024

Link: https://doi.org/10.1016/..

3

Effect of Treatment of Residual Disease After Immunotherapy..:

Moinard-Butot, F. ; Oriel, M. ; Tricard, T....
Clinical Genitourinary Cancer. 22 (2024) 5 - p. 102134 , 2024

Link: https://doi.org/10.1016/..

4

Raman identification of CaCO3 polymorphs in concrete prepar..:

Marchetti, M. ; Gouadec, G. ; Offroy, M....
Materials and Structures. 57 (2024) 2 - p. , 2024

Link: https://doi.org/10.1617/..

5

Prognostic value of EndoPredict test in patients with hormo..:

Penault-Llorca, F. ; Dalenc, F. ; Chabaud, S....
ESMO Open. 9 (2024) 5 - p. 103443 , 2024

Link: https://doi.org/10.1016/..

6

Analyse descriptive de la plus grande cohorte mondiale de p..:

Bailly, C. ; Barthelemy, P. ; Somme, F....
Médecine Nucléaire. 48 (2024) 2 - p. 55 , 2024

Link: https://doi.org/10.1016/..

7

TROPHY-U-01, a phase II open-label study of sacituzumab gov..:

Loriot, Y. ; Petrylak, D.P. ; Rezazadeh Kalebasty, A....
Annals of Oncology. 35 (2024) 4 - p. 392-401 , 2024

Link: https://doi.org/10.1016/..

8

Level 2 vena cava thrombectomy and robot assisted radical n..:

Margue, G. ; Thouvenin, J. ; Sionneau, B....
European Urology Open Science. 55 (2023) - p. S239 , 2023

Link: https://doi.org/10.1016/..

9

Clinical characterisation, prognosis, and assessment of pre..:

Vallois, L. ; Lindner, V. ; Barthélémy, P.
European Urology Open Science. 57 (2023) - p. S230-S231 , 2023

Link: https://doi.org/10.1016/..

10

IO-Synthesise RCC: relationship between baseline health-rel..:

Bedke, J. ; Thiery-Vuillemin, A. ; Grimm, M.O....
European Urology Open Science. 57 (2023) - p. S258-S259 , 2023

Link: https://doi.org/10.1016/..

11

Complete response in first-line metastatic renal cell carci..:

Boudier, P. ; Moinard-Butot, F. ; Thouvenin, J....
European Urology Open Science. 57 (2023) - p. S211 , 2023

Link: https://doi.org/10.1016/..

12

Avelumab first-line maintenance treatment for advanced urot..:

Grivas, P. ; Grande, E. ; Davis, I.D....
ESMO Open. 8 (2023) 6 - p. 102050 , 2023

Link: https://doi.org/10.1016/..

13

PRAISE : décrire les effets immunologiques secondaires à l'..:

Gottenberg, J.E. ; Cloarec, N. ; Monnet, I....
Revue du Rhumatisme. 89 (2022) - p. A38 , 2022

Link: https://doi.org/10.1016/..

14

Résultats intermédiaires sur les 658 premiers patients de l..:

Sebbag, E. ; Cloarec, N. ; Monnet, I....
Revue du Rhumatisme. 89 (2022) - p. A87-A88 , 2022

Link: https://doi.org/10.1016/..

15

TiNivo: safety and efficacy of tivozanib-nivolumab combinat..:

Albiges, L. ; Barthélémy, P. ; Gross-Goupil, M....
Annals of Oncology. 32 (2021) 1 - p. 97-102 , 2021

Link: https://doi.org/10.1016/..